引用本文:
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1590次   下载 1331 本文二维码信息
码上扫一扫!
分享到: 微信 更多
三种淋巴瘤细胞CD52抗原呈现稳定性研究及其应用
秦海艳1,陈继军1,安晨1,熊颖1,叶星1,南建军1,毛晓燕1
兰州生物制品研究所有限责任公司 第四研究室
摘要:
评估淋巴瘤细胞MC/CAR、HUT78和RAMOS的CD52抗原呈现稳定性,并比较三种细胞用于抗CD52单抗活性检测中的优劣性。采用免疫荧光法检测淋巴瘤细胞MC/CAR、HUT78和RAMOS的CD52抗原呈现率,分析MC/CAR、HUT78和RAMOS传代培养5~20代CD52抗原呈现稳定性。分别以MC/CAR、HUT78和RAMOS作为抗CD52单抗结合活性和补体依赖细胞毒性的靶细胞进行检测,并比较其优劣性。结果显示,MC/CAR、RAMOS和HUT78的CD52抗原呈现率分别为95.5%、63.2%和38.3%。MC/CAR传代培养5~20代CD52抗原呈现率均大于90%。RAMOS传代培养5~13代CD52抗原呈现率介于60%~67%,第14~15代CD52抗原呈现率介于50%~60%,第16~20代细胞CD52抗原呈现率介于40%~50%。HUT78传代培养5~20代CD52抗原呈现率介于26.7%~38.9%。淋巴瘤细胞MC/CAR在抗CD52单抗的结合活性检测中呈现出更好的剂量依赖曲线。淋巴瘤细胞RAMOS在抗CD52单抗的补体依赖细胞毒性检测中呈现出更好的剂量效应曲线。CD52抗原呈现率方面MC/CAR>RAMOS>HUT78。结果表明,MC/CAR更适用于抗CD52单抗的结合活性的检测,RAMOS适用于抗CD52单抗的补体依赖细胞毒性检测。
关键词:  CD52抗原  HUT78  RAMOS  MC/CAR  抗原呈现率
DOI:10.14188/j.ajsh.2019.05.009
分类号:Q291
基金项目:兰州市科技重大专项 2017-2-1兰州市科技重大专项(2017-2-1)
Appearance stability of CD52 antigen in three kinds of lymphoma cells and its application
QIN Haiyan1,CHEN Jijun1,AN Chen1,XIONG Ying1,YE Xing1,NAN Jianjun1,MAO Xiaoyan1
Fourth Department of Research, Lanzhou Institute of Biological Products Co., Ltd., Lanzhou 730046, Gansu, China
Abstract:
To evaluate the appearance stability of CD52 antigen in lymphoma cells MC/CAR,HUT78 and RAMOS, and to compare the advantages and disadvantages of the three cells used in the biological activity detection of anti-CD52 monoclonal antibody, the appearance rate of CD52 antigen in three cells were detected by immunofluorescence. The appearance stability of CD52 antigen in MC/CAR, HUT78 and RAMOS were analyzed for 5~20 generations. The binding activity and complement dependent cytotoxicity of anti-CD52 monoclonal antibody were performed using MC/CAR, HUT78 and RAMOS as target cells, respectively, and their advantages and disadvantages were compared. CD52 antigen appearance rate of MC/CAR, HUT78 and RAMOS were 95.5%, 63.2%, and 38.3%, respectively. CD52 antigen appearance rates of MC/CAR were all > 90% at 5~20 generations. CD52 antigen appearance rate of RAMOS was between 60% and 67% at 5~13 generations, between 50% and 60% at 14~15 generations, and between 40% and 50% at 16~20 generations. CD52 antigen appearance rate of HUT78 was between 26.7% and 38.9% at 5~20 generations. MC/CAR showed a better dose-dependent curve in binding activity of anti-CD52 monoclonal antibodies. RAMOS showed a better dose-response curve in complement dependent cytotoxicity activity of anti-CD52 monoclonal antibody. The appearance rate of CD52 antigen in lymphoma cells were MC/CAR>RAMOS>HUT78. MC/CAR was more suitable for the binding activity detection of anti-CD52 monoclonal antibody. RAMOS was more suitable for complement dependent cytotoxicity detection of anti-CD52 monoclonal antibody.
Key words:  CD52 antigen  HUT78  RAMOS  MC/CAR  antigen appearance rate